THURSDAY, June 9 (HealthDay News) -- Treatment with hormone
replacement therapy (HRT), if tailored to an individual woman's
needs, appears to be safe during menopause, according to a report
scheduled for release Friday at the World Congress on Menopause in
"The evidence is quite compelling that young, healthy women do quite well and benefit in several ways," said Dr. Roger Lobo, professor of obstetrics and gynecology at Columbia University in New York City, a member of the working group that updated the HRT guidelines for the International Menopause Society.
"I think the main finding is, the major indication for HRT is symptoms," Lobo said. "Young" refers to women 50 to 59 at the start of menopause, he said.
The recommendations may help to settle the controversy that
arose in 2002 on the heels of an alarming report from the
large-scale Women's Health Initiative (WHI). That study, which
began as a prevention trial for heart disease, concluded that HRT
did not protect the heart and that its risks outweighed the
benefits for preventing chronic disease.
But when the menopause society's writing group reviewed the WHI
and additional evidence, they concluded HRT is generally safe for
most women at the time of menopause.
Also, by relieving bothersome menopausal symptoms such as hot
flashes and vaginal dryness, Lobo said HRT may improve quality of
life and sexuality. It may also help prevent osteoporosis and colon
cancer, the authors said.
"And in these women under 60, there is early evidence there is benefit for heart health as well," Lobo said.
Because HRT treatment is highly individual, a woman's decision
to start or continue treatment should be discussed with her doctor,
the authors said.
The updated recommendations, published in the journal
Climacteric, also urge women using HRT to review the decision annually with their doctor and to discontinue it every few years to see if symptoms return.
Short-term use is advised, just for as long as needed for
symptom relief and at the lowest dose that relieves symptoms.
One reason for the reversal is that the average age of the
participants in the earlier study was 63, which is typically after
menopausal symptoms end, and an unusual time to start hormone
"The pendulum swung back from its peak negative sentiment following more detailed data from the WHI study that demonstrated the importance of the age at initiation and the good safety profile of HRT in women younger than 60 years," the authors wrote.
"HRT remains the most effective therapy for vasomotor symptoms [such as hot flashes] and urogenital atrophy [including vaginal dryness]," the review said.
"Other menopause-related complaints, such as joint and muscle pains, mood swings, sleep disturbances and sexual dysfunction (including reduced libido) may improve during HRT," they authors continued.
Dr. Elizabeth Poynor, a gynecologist and gynecologic oncologist
at Lenox Hill Hospital in New York City, who is familiar with the
study, thinks it is sound.
"We are coming full circle with HRT," she said. "We are realizing for some women it really does have benefit. We went from giving HRT to everybody to giving HRT to nobody [after the 2002 findings] to really individualizing it, which is how we should utilize HRT."
HRT, she said, is "definitely not a one-size-fits-all situation,
and that is what I like about this position statement."
The menopause society paid for the review and received no money
from outside sources.
To learn more about midlife health, visit the
American Congress of Obstetricians and
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.